# Nan Fung Group Holdings Ltd 13F Q2 2026: $131 million

Nan Fung Group Holdings Ltd reported $131 million in 13F securities across 25 positions for the quarter ended June 30, 2026, in a combination report filed August 13, 2026. Its largest holding was Maplight Therapeutics Inc at $34.8 million, 26.5% of the reported value. Since Q1 2026 it opened 2 new positions and exited 1.

SpecStream is the live web data engine for teams and agents. It reads the SEC's Form 13F data sets each quarter, and this page is that reading, keyed on the manager's CIK and the security's CUSIP. Ask for the managers or the holdings you track, and each new 13F filing arrives in your sheet, CRM, Slack or agent as the SEC publishes it.

- Quarter: Q2 2026, the quarter ended June 30, 2026
- Reported value: $131,488,918
- Positions: 25
- Filed: August 13, 2026
- Report type: 13F combination report
- CIK: 1782539
- Form 13F file number: 028-21371
- Business address: 17th Floor, Airside 2 Concorde Road, Kai Tak, 00000 Hong Kong
- SEC filing: [0001012975-26-000761](https://www.sec.gov/Archives/edgar/data/1782539/000101297526000761/0001012975-26-000761-index.htm)

## Top 25 holdings by value

The largest of 25 positions by reported value at the end of the quarter ended June 30, 2026. Put and call options are marked in the class. Change is in shares or principal against the filing for the quarter ended March 31, 2026.

| Issuer | Class | Shares or principal | Value | Change since Q1 2026 |
| --- | --- | --- | --- | --- |
| [Maplight Therapeutics Inc](https://specstream.ai/data/institutional-holders/maplight-therapeutics-inc-56565p103) | COM | 971,253 | $34.8 million | No change |
| [LB Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/lb-pharmaceuticals-inc-50180m108) | COM SHS | 630,657 | $20.5 million | No change |
| [Evommune Inc](https://specstream.ai/data/institutional-holders/evommune-inc-30054y107) | COM SHS | 1,441,032 | $19.2 million | No change |
| [Cybin Inc](https://specstream.ai/data/institutional-holders/cybin-inc-23256x407) | COM NEW | 987,222 | $6.5 million | +527,222 |
| [Incyte Corp](https://specstream.ai/data/institutional-holders/incyte-corp-45337c102) | COM | 53,742 | $6.1 million | No change |
| [Rhythm Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/rhythm-pharmaceuticals-inc-76243j105) | COM | 49,120 | $5.5 million | No change |
| [Beone Medicines LTD](https://specstream.ai/data/institutional-holders/beone-medicines-ltd-07725l102) | SPONSORED ADS | 15,722 | $4.5 million | No change |
| [Oculis Holding AG](https://specstream.ai/data/institutional-holders/oculis-holding-ag-h5870p102) | ORDINARY SHARES | 300,565 | $4.2 million | -50,180 |
| [Ascendis Pharma A/S](https://specstream.ai/data/institutional-holders/ascendis-pharma-a-s-k08588103) | ORD SHS | 13,600 | $3.6 million | New |
| [Revolution Medicines Inc](https://specstream.ai/data/institutional-holders/revolution-medicines-inc-76155x100) | COM | 19,253 | $3.6 million | No change |
| [Kymera Therapeutics Inc](https://specstream.ai/data/institutional-holders/kymera-therapeutics-inc-501575104) | COM | 30,875 | $3.5 million | No change |
| [Madrigal Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/madrigal-pharmaceuticals-inc-558868105) | COM | 5,672 | $3 million | No change |
| [Celcuity Inc](https://specstream.ai/data/institutional-holders/celcuity-inc-15102k100) | COM | 28,300 | $3 million | No change |
| [Acadia Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/acadia-pharmaceuticals-inc-004225108) | COM | 102,984 | $2.6 million | No change |
| [Argenx Se](https://specstream.ai/data/institutional-holders/argenx-se-04016x101) | SPONSORED ADR | 2,800 | $2.6 million | No change |
| [Recursion Pharmaceuticals in](https://specstream.ai/data/institutional-holders/recursion-pharmaceuticals-in-75629v104) | CL A | 595,287 | $2.2 million | No change |
| [Procore Technologies Inc](https://specstream.ai/data/institutional-holders/procore-technologies-inc-74275k108) | COM | 53,299 | $2.2 million | No change |
| [Harmony Biosciences Hldgs in](https://specstream.ai/data/institutional-holders/harmony-biosciences-hldgs-in-413197104) | COM | 27,049 | $984,854 | No change |
| [Insmed Inc](https://specstream.ai/data/institutional-holders/insmed-inc-457669307) | COM PAR $.01 | 6,580 | $701,560 | No change |
| [Ishares Ethereum TR](https://specstream.ai/data/institutional-holders/ishares-ethereum-tr-46438r105) | SHS | 50,549 | $601,028 | No change |
| [Ishares Bitcoin Trust ETF](https://specstream.ai/data/institutional-holders/ishares-bitcoin-trust-etf-46438f101) | SHS BEN INT | 15,968 | $531,575 | No change |
| [Chime Finl Inc](https://specstream.ai/data/institutional-holders/chime-finl-inc-16935c109) | COM SHS CL A | 21,075 | $431,616 | New |
| [Rani Therapeutics Hldgs Inc](https://specstream.ai/data/institutional-holders/rani-therapeutics-hldgs-inc-753018100) | COM CL A | 493,584 | $375,321 | No change |
| [Entrada Therapeutics Inc](https://specstream.ai/data/institutional-holders/entrada-therapeutics-inc-29384c108) | COM | 49,082 | $361,244 | No change |
| [Bolt Biotherapeutics Inc](https://specstream.ai/data/institutional-holders/bolt-biotherapeutics-inc-097702203) | COM NEW | 5,000 | $19,250 | -24,250 |

## New positions in Q2 2026

2 positions not in the filing for the quarter ended March 31, 2026.

| Issuer | Class | Shares or principal | Value |
| --- | --- | --- | --- |
| [Ascendis Pharma A/S](https://specstream.ai/data/institutional-holders/ascendis-pharma-a-s-k08588103) | ORD SHS | 13,600 | $3.6 million |
| [Chime Finl Inc](https://specstream.ai/data/institutional-holders/chime-finl-inc-16935c109) | COM SHS CL A | 21,075 | $431,616 |

## Positions exited in Q2 2026

1 position in the filing for the quarter ended March 31, 2026 and not in this one, with the shares and value reported then.

| Issuer | Class | Shares or principal | Value |
| --- | --- | --- | --- |
| Ascendis Pharma A/S | SPONSORED ADR | 13,600 | $3.1 million |

## Also on SpecStream

- [Nan Fung Group Holdings Ltd Form 13F filing on EDGAR](https://www.sec.gov/Archives/edgar/data/1782539/000101297526000761/0001012975-26-000761-index.htm)
- [Largest institutional managers by 13F value](https://specstream.ai/data/institutional-holdings)
- [Most widely held securities in 13F filings](https://specstream.ai/data/institutional-holders)

Source: [the SEC's Form 13F data sets](https://www.sec.gov/data-research/sec-markets-data/form-13f-data-sets). Public data published by the US Securities and Exchange Commission (US government work). Managers report these holdings themselves in Form 13F, and the SEC does not check or guarantee them. Form 13F lists long positions in US listed equities, some options and convertible notes held at the end of the quarter, and leaves out short positions, cash, most bonds and holdings below the reporting threshold. Values are market values in US dollars as the manager filed them. A manager can ask the SEC to keep some positions confidential for a time. This page uses SEC data and is not endorsed or certified by the SEC.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [British restaurants in the United States](https://specstream.ai/data/businesses/british-restaurants/united-states)
- [Chiropractic clinics in the United States](https://specstream.ai/data/businesses/chiropractic-clinics/united-states)
- [Damage restoration companies in the United States](https://specstream.ai/data/businesses/damage-restoration-companies/united-states)
- [Electronic equipment suppliers in the United States](https://specstream.ai/data/businesses/electronic-equipment-suppliers/united-states)
- [Financial advisory firms in the United States](https://specstream.ai/data/businesses/financial-advisory-firms/united-states)
- [Greek restaurants in the United States](https://specstream.ai/data/businesses/greek-restaurants/united-states)
